These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 18958831)

  • 1. [Posaconazole: another triazole antifungal of the new generation?].
    Müller C; Kohl V; Farowski F; Cornely OA
    Dtsch Med Wochenschr; 2008 Nov; 133(45):2345-8. PubMed ID: 18958831
    [No Abstract]   [Full Text] [Related]  

  • 2. Posaconazole: a broad-spectrum triazole antifungal.
    Torres HA; Hachem RY; Chemaly RF; Kontoyiannis DP; Raad II
    Lancet Infect Dis; 2005 Dec; 5(12):775-85. PubMed ID: 16310149
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Posaconazole: an extended-spectrum triazole antifungal agent.
    Schiller DS; Fung HB
    Clin Ther; 2007 Sep; 29(9):1862-86. PubMed ID: 18035188
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Posaconazole: a new broad-spectrum antifungal agent.
    Kwon DS; Mylonakis E
    Expert Opin Pharmacother; 2007 Jun; 8(8):1167-78. PubMed ID: 17516880
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Safety of triazole antifungal drugs in patients with cancer.
    Cronin S; Chandrasekar PH
    J Antimicrob Chemother; 2010 Mar; 65(3):410-6. PubMed ID: 20035021
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [The latest data on posaconazole].
    Paugam A
    Med Mal Infect; 2007 Feb; 37(2):71-6. PubMed ID: 17267154
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Management of systemic fungal infections: alternatives to itraconazole.
    Herbrecht R; Nivoix Y; Fohrer C; Natarajan-Amé S; Letscher-Bru V
    J Antimicrob Chemother; 2005 Sep; 56 Suppl 1():i39-i48. PubMed ID: 16120633
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Posaconazole: new indications. Prevention of invasive mycosis and treatment of oropharyngeal candidiasis: no therapeutic advantage.
    Prescrire Int; 2008 Dec; 17(98):233. PubMed ID: 19422144
    [No Abstract]   [Full Text] [Related]  

  • 9. Clinical efficacy of new antifungal agents.
    Kauffman CA
    Curr Opin Microbiol; 2006 Oct; 9(5):483-8. PubMed ID: 16904366
    [TBL] [Abstract][Full Text] [Related]  

  • 10. New triazoles and echinocandins: mode of action, in vitro activity and mechanisms of resistance.
    Fera MT; La Camera E; De Sarro A
    Expert Rev Anti Infect Ther; 2009 Oct; 7(8):981-98. PubMed ID: 19803707
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Posaconazole.
    Keating GM
    Drugs; 2005; 65(11):1553-67; discussion 1568-9. PubMed ID: 16033292
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Triazole antifungal agents: practice guidelines of therapeutic drug monitoring and perspectives in treatment optimization].
    Scodavolpe S; Quaranta S; Lacarelle B; Solas C
    Ann Biol Clin (Paris); 2014; 72(4):391-404. PubMed ID: 25119797
    [TBL] [Abstract][Full Text] [Related]  

  • 13. SCH 56592.
    Drugs R D; 1999 Feb; 1(2):184-6. PubMed ID: 10566022
    [No Abstract]   [Full Text] [Related]  

  • 14. Advances in systemic antifungal therapy.
    Stevens DA
    Clin Dermatol; 2012; 30(6):657-61. PubMed ID: 23068153
    [TBL] [Abstract][Full Text] [Related]  

  • 15. ER 30346. BMS 207147.
    Drugs R D; 1999 Feb; 1(2):170-1. PubMed ID: 10566016
    [No Abstract]   [Full Text] [Related]  

  • 16. Antifungal azoles: old and new.
    Blyth CC
    Pediatr Infect Dis J; 2011 Jun; 30(6):506-7. PubMed ID: 21587027
    [No Abstract]   [Full Text] [Related]  

  • 17. Posaconazole's impact on prophylaxis and treatment of invasive fungal infections: an update.
    Smith WJ; Drew RH; Perfect JR
    Expert Rev Anti Infect Ther; 2009 Mar; 7(2):165-81. PubMed ID: 19254165
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Breakpoints for posaconazole susceptibility testing: background and discussion about the need of establishing values.
    Fleck R; Hof H
    Mycoses; 2008 Sep; 51 Suppl 2():1-4. PubMed ID: 18721327
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacologic and clinical evaluation of posaconazole.
    Moore JN; Healy JR; Kraft WK
    Expert Rev Clin Pharmacol; 2015 May; 8(3):321-34. PubMed ID: 25916666
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Posaconazole: clinical pharmacology and potential for management of fungal infections.
    Groll AH; Walsh TJ
    Expert Rev Anti Infect Ther; 2005 Aug; 3(4):467-87. PubMed ID: 16107193
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.